|
1. Oylumlu M, Yıldız A, Oylumlu M, Yüksel M, Polat N, Bilik MZ, et al. Platelet-to-lymphocyte ratio is a predictor of in-hospital mortality patients with acute coronary syndrome. Anatol J Cardiol. 2015;15:277-83. doi: 10.5152/akd.2014.5366. 2. Xu R, Chen L, Yan C, Xu H, Cao G. Elevated platelet‐to‐lymphocyte ratio as a predictor of all‐cause and cardiovascular mortality in hypertensive individuals. J Clin Hypertens (Greenwich). 2025;27:e14980. 3. Park JJ, Jang HJ, Oh IY, Yoon CH, Suh JW, Cho YS, et al. Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2013;111:636-42. doi: 10.1016/j.amjcard.2012.11.012. 4. Pruc M, Peacock FW, Rafique Z, Swieczkowski D, Kurek K, Tomaszewska M, et al. The Prognostic Role of Platelet-to-Lymphocyte Ratio in Acute Coronary Syndromes: A Systematic Review and Meta-Analysis. J Clin Med. 2023;12. doi: 10.3390/jcm12216903. 5. Zhang Y, Zhang A, Wei L, Ren K, Wang Q, Shao B, et al. A high platelet-to-lymphocyte ratio predicts all-cause mortality and cardiovascular mortality in maintenance hemodialysis patients. Ren Fail. 2023;45:2258228. doi: 10.1080/0886022X.2023.2258228. 6. Ye GL, Chen Q, Chen X, Liu YY, Yin TT, Meng QH, et al. The prognostic role of platelet-to-lymphocyte ratio in patients with acute heart failure: A cohort study. Sci Rep. 2019;9:10639. doi: 10.1038/s41598-019-47143-2. 7. Wang H, Li L, Ma Y. Platelet-to-lymphocyte ratio a potential prognosticator in acute myocardial infarction: A prospective longitudinal study. Clin Cardiol. 2023;46:632-8. doi: 10.1002/clc.24002. 8. Soylu K, Gedikli Ö, Dagasan G, Aydin E, Aksan G, Nar G, et al. Neutrophil-to-lymphocyte ratio predicts coronary artery lesion complexity and mortality after non-ST-segment elevation acute coronary syndrome. Rev Port Cardiol. 2015;34:465-71. doi: 10.1016/j.repc.2015.01.013. 9. Ismail MA, abdel Rady Metawaa MA, Farouk MM, Mohamed Salah LT. The Role of Neutrophil to Lymphocyte Ratio and Platelet Indices as Markers of Inflammation in Acute Coronary Syndrome. QJM: Int J Med. 2024;117. doi:10.1093/qjmed/hcae175.184. 10. Dong CH, Wang ZM, Chen SY. Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome: A systematic review and meta-analysis. Clin Biochem. 2018;52:131-6. doi: 10.1016/j.clinbiochem.2017.11.008. 11. Suliman MARM, Juma AAB, Almadhani AAA, Pathare AV, Alkindi SSA, Werner FU. Predictive value of neutrophil to lymphocyte ratio in outcomes of patients with acute coronary syndrome. Arch Med Res. 2010;41:618-22. doi: 10.1016/j.arcmed.2010.11.006. 12. Nohria R, Viera AJ. Acute Coronary Syndrome: diagnosis and initial management. Am Fam Physician. 2024;109:34-42. 13. Gao Y, Li Y, Chen X, Wu C, Guo Z, Bai G, et al. The Systemic Inflammation Index Predicts Poor Clinical Prognosis in Patients with Initially Diagnosed Acute Coronary Syndrome Undergoing Primary Coronary Angiography. J Inflamm Res. 2023;16:5205-19. doi: 10.2147/JIR.S435398. 14. Ertürk M, Caglar FNT, Bıyık İ, Işıksaçan N, Yazan S, Yıldırım MR, et al. Correlations between hematological indicators and other known markers in acute coronary syndromes. JUCVM. 2017; 5: 67-74. doi: 10.15511/ejcm.17.00467. 15. Shahabirabori V, Shahabirabori R, Hatami Y, Hajizadeh R, Rahimi B. Relationship of Peripheral Blood Platelet to Lymphocyte Ratio with the Severity of Coronary Disease in Patients with Acute Coronary Syndrome in Taleghani Hospital, Urmia, Iran. J Ilam Univ Med Sci. 2021;29:30-8. 16. AlHammouri HM, Mustafa O, Mash'al N, Suwan S, Al‐Rababa'h M, Turk AZ, et al. Inflammatory Markers and Contrast‐Induced Nephropathy Risk: A Meta‐Analysis of NLR and PLR in ACS Patients Undergoing Percutaneous Coronary Intervention. Catheter Cardiovasc Interv. 2025; 106:2361-2373. doi: 10.1002/ccd.70056. 17. Pruc M, Kubica J, Banach M, Swieczkowski D, Rafique Z, Peacock WF, et al. Diagnostic and prognostic performance of the neutrophil-to-lymphocyte ratio in acute coronary syndromes: A meta-analysis of 90 studies including 45 990 patients. Kardiol Pol. 2024;82:276-84. doi: 10.33963/v.phj.99554. 18. Ghasempour Dabaghi G, Rabiee Rad M, Mortaheb M, Darouei B, Amani-Beni R, Mazaheri-Tehrani S, et al. The Neutrophil-to-Lymphocyte Ratio Predicts Cardiovascular Outcomes in Patients With Diabetes: A Systematic Review and Meta-Analysis. Cardiol Rev. 2025;33:202-11. doi: 10.1097/CRD.0000000000000820. 19. Zengin A, Karaca M, Aruğaslan E, Yıldırım E, Karataş MB, Çanga Y, et al. Performance of neutrophil to lymphocyte ratio for the prediction of long-term morbidity and mortality in coronary slow flow phenomenon patients presented with non-ST segment elevation acute coronary syndrome. J Cardiovasc Thorac Res. 2021;13:125. doi: 10.34172/jcvtr.2021.12. 20. Lao M, Liu H, Cai X, Zhang Y, Liu T, Li G, et al. The Monocyte-to-Lymphocyte Ratio Exhibits A Superior Prognostic Value in Patients with Newly Diagnosed Acute Coronary Syndrome. Rev Cardiovasc Med. 2025; 26:39917. doi: 10.31083/RCM39917. 21. Kofos C, Papazoglou AS, Fyntanidou B, Samaras A, Stachteas P, Nasoufidou A, et al. Platelet-to-Lymphocyte and Glucose-to-Lymphocyte Ratios as Prognostic Markers in Hospitalized Patients with Acute Coronary Syndrome. J Cardiovasc Dev Dis. 2025; 12:334. doi: 10.3390/jcdd12090334. 22. Wang H, Zulikaier T, Yumaierjiang B, Lyu S, He PJRiCM. Platelet-to-lymphocyte ratio efficiency in predicting major adverse cardiovascular events after percutaneous coronary intervention in acute coronary syndromes: a meta-analysis. Rev Cardiovasc Med. 2025;26:27942. doi: 10.31083/RCM27942. 23. Khawaldeh BMH, Ameer F, Al-Hawadi BS, Alhawadi SS, Ali AOH, Eltamawy KMA, et al. prognostic value of neutrophil-to-lymphocyte ratio in cardiovascular disease: a systematic review and meta-analysis. Gland Surg. 2026;11:41-57. 24. Oylumlu M, Yıldız A, Oylumlu M, Yüksel M, Polat N, Bilik MZ, et al. Platelet-to-lymphocyte ratio is a predictor of in-hospital mortality patients with acute coronary syndrome. Anatol J Cardiol. 2015;15:277-83. doi: 10.5152/akd.2014.5366. 25. Xu R, Chen L, Yan C, Xu H, Cao G. Elevated platelet‐to‐lymphocyte ratio as a predictor of all‐cause and cardiovascular mortality in hypertensive individuals. J Clin Hypertens (Greenwich). 2025;27:e14980. 26. Park JJ, Jang HJ, Oh IY, Yoon CH, Suh JW, Cho YS, et al. Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2013;111:636-42. doi: 10.1016/j.amjcard.2012.11.012. 27. Pruc M, Peacock FW, Rafique Z, Swieczkowski D, Kurek K, Tomaszewska M, et al. The Prognostic Role of Platelet-to-Lymphocyte Ratio in Acute Coronary Syndromes: A Systematic Review and Meta-Analysis. J Clin Med. 2023;12. doi: 10.3390/jcm12216903. 28. Zhang Y, Zhang A, Wei L, Ren K, Wang Q, Shao B, et al. A high platelet-to-lymphocyte ratio predicts all-cause mortality and cardiovascular mortality in maintenance hemodialysis patients. Ren Fail. 2023;45:2258228. doi: 10.1080/0886022X.2023.2258228. 29. Ye GL, Chen Q, Chen X, Liu YY, Yin TT, Meng QH, et al. The prognostic role of platelet-to-lymphocyte ratio in patients with acute heart failure: A cohort study. Sci Rep. 2019;9:10639. doi: 10.1038/s41598-019-47143-2. 30. Wang H, Li L, Ma Y. Platelet-to-lymphocyte ratio a potential prognosticator in acute myocardial infarction: A prospective longitudinal study. Clin Cardiol. 2023;46:632-8. doi: 10.1002/clc.24002. 31. Soylu K, Gedikli Ö, Dagasan G, Aydin E, Aksan G, Nar G, et al. Neutrophil-to-lymphocyte ratio predicts coronary artery lesion complexity and mortality after non-ST-segment elevation acute coronary syndrome. Rev Port Cardiol. 2015;34:465-71. doi: 10.1016/j.repc.2015.01.013. 32. Ismail MA, abdel Rady Metawaa MA, Farouk MM, Mohamed Salah LT. The Role of Neutrophil to Lymphocyte Ratio and Platelet Indices as Markers of Inflammation in Acute Coronary Syndrome. QJM: Int J Med. 2024;117. doi:10.1093/qjmed/hcae175.184. 33. Dong CH, Wang ZM, Chen SY. Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome: A systematic review and meta-analysis. Clin Biochem. 2018;52:131-6. doi: 10.1016/j.clinbiochem.2017.11.008. 34. Suliman MARM, Juma AAB, Almadhani AAA, Pathare AV, Alkindi SSA, Werner FU. Predictive value of neutrophil to lymphocyte ratio in outcomes of patients with acute coronary syndrome. Arch Med Res. 2010;41:618-22. doi: 10.1016/j.arcmed.2010.11.006. 35. Nohria R, Viera AJ. Acute Coronary Syndrome: diagnosis and initial management. Am Fam Physician. 2024;109:34-42. 36. Gao Y, Li Y, Chen X, Wu C, Guo Z, Bai G, et al. The Systemic Inflammation Index Predicts Poor Clinical Prognosis in Patients with Initially Diagnosed Acute Coronary Syndrome Undergoing Primary Coronary Angiography. J Inflamm Res. 2023;16:5205-19. doi: 10.2147/JIR.S435398. 37. Ertürk M, Caglar FNT, Bıyık İ, Işıksaçan N, Yazan S, Yıldırım MR, et al. Correlations between hematological indicators and other known markers in acute coronary syndromes. JUCVM. 2017; 5: 67-74. doi: 10.15511/ejcm.17.00467. 38. Shahabirabori V, Shahabirabori R, Hatami Y, Hajizadeh R, Rahimi B. Relationship of Peripheral Blood Platelet to Lymphocyte Ratio with the Severity of Coronary Disease in Patients with Acute Coronary Syndrome in Taleghani Hospital, Urmia, Iran. J Ilam Univ Med Sci. 2021;29:30-8. 39. AlHammouri HM, Mustafa O, Mash'al N, Suwan S, Al‐Rababa'h M, Turk AZ, et al. Inflammatory Markers and Contrast‐Induced Nephropathy Risk: A Meta‐Analysis of NLR and PLR in ACS Patients Undergoing Percutaneous Coronary Intervention. Catheter Cardiovasc Interv. 2025; 106:2361-2373. doi: 10.1002/ccd.70056. 40. Pruc M, Kubica J, Banach M, Swieczkowski D, Rafique Z, Peacock WF, et al. Diagnostic and prognostic performance of the neutrophil-to-lymphocyte ratio in acute coronary syndromes: A meta-analysis of 90 studies including 45 990 patients. Kardiol Pol. 2024;82:276-84. doi: 10.33963/v.phj.99554. 41. Ghasempour Dabaghi G, Rabiee Rad M, Mortaheb M, Darouei B, Amani-Beni R, Mazaheri-Tehrani S, et al. The Neutrophil-to-Lymphocyte Ratio Predicts Cardiovascular Outcomes in Patients With Diabetes: A Systematic Review and Meta-Analysis. Cardiol Rev. 2025;33:202-11. doi: 10.1097/CRD.0000000000000820. 42. Zengin A, Karaca M, Aruğaslan E, Yıldırım E, Karataş MB, Çanga Y, et al. Performance of neutrophil to lymphocyte ratio for the prediction of long-term morbidity and mortality in coronary slow flow phenomenon patients presented with non-ST segment elevation acute coronary syndrome. J Cardiovasc Thorac Res. 2021;13:125. doi: 10.34172/jcvtr.2021.12. 43. Lao M, Liu H, Cai X, Zhang Y, Liu T, Li G, et al. The Monocyte-to-Lymphocyte Ratio Exhibits A Superior Prognostic Value in Patients with Newly Diagnosed Acute Coronary Syndrome. Rev Cardiovasc Med. 2025; 26:39917. doi: 10.31083/RCM39917. 44. Kofos C, Papazoglou AS, Fyntanidou B, Samaras A, Stachteas P, Nasoufidou A, et al. Platelet-to-Lymphocyte and Glucose-to-Lymphocyte Ratios as Prognostic Markers in Hospitalized Patients with Acute Coronary Syndrome. J Cardiovasc Dev Dis. 2025; 12:334. doi: 10.3390/jcdd12090334. 45. Wang H, Zulikaier T, Yumaierjiang B, Lyu S, He PJRiCM. Platelet-to-lymphocyte ratio efficiency in predicting major adverse cardiovascular events after percutaneous coronary intervention in acute coronary syndromes: a meta-analysis. Rev Cardiovasc Med. 2025;26:27942. doi: 10.31083/RCM27942. 46. Khawaldeh BMH, Ameer F, Al-Hawadi BS, Alhawadi SS, Ali AOH, Eltamawy KMA, et al. prognostic value of neutrophil-to-lymphocyte ratio in cardiovascular disease: a systematic review and meta-analysis. Gland Surg. 2026;11:41-57.
|
